Last quarter (Q3 2023), BioHarvest Sciences's total revenue was $3.24M, an increase of 113.51% from the same quarter last year. In Q3, BioHarvest Sciences's net income was $-1.73M. See BioHarvest Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Apr 19
Total Revenue	$ 10.60M	$ 5.50M	$ 2.10M	$ 396.00K	$ 218.00K	-
Cost of Revenue	$ 5.36M	$ 3.05M	$ 1.43M	$ 258.00K	$ 189.00K	-
Gross Profit	$ 5.23M	$ 2.45M	$ 670.00K	$ 138.00K	$ 29.00K	-
Operating Expense	$ 15.19M	$ 13.06M	$ 9.16M	$ 6.30M	$ 2.34M	$ 4.36M
Operating Income	$ -9.95M	$ -10.61M	$ -8.49M	$ -6.17M	$ -2.31M	$ -4.36M
Net Non Operating Interest Income Expense	$ 2.48M	$ 37.00K	$ 852.00K	$ -405.00K	$ -3.00M	$ -780.00K
Other Income Expense	$ 891.00K	$ 891.00K	$ -484.00K	$ -13.00K	-	-
Pretax Income	$ -8.13M	$ -11.24M	$ -9.83M	$ -6.58M	$ -5.31M	$ -5.13M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -8.13M	$ -11.24M	$ -9.83M	$ -6.58M	$ -5.31M	$ -5.13M
Basic EPS	-	$ -0.02	$ -0.02	$ -0.02	$ -0.05	$ -0.09
Diluted EPS	-	$ -0.02	$ -0.02	$ -0.02	$ -0.05	$ -0.09
Basic Average Shares	$ 1.86B	$ 456.88M	$ 435.67M	$ 339.98M	$ 103.24M	$ 57.19M
Diluted Average Shares	$ 1.86B	$ 456.88M	$ 435.67M	$ 339.98M	$ 103.24M	$ 57.19M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	$ 0.00	-	-
Total Expenses	$ 20.55M	$ 16.11M	-	$ 6.56M	$ 2.53M	$ 4.36M
Interest Expense	-	-	-	$ 522.00K	$ 3.76M	$ 780.00K
Net Income From Continuing And Discontinued Operation	$ -8.13M	$ -11.24M	$ -9.83M	$ -6.58M	$ -5.31M	$ -5.13M
Normalized Income	$ -6.72M	$ -8.26M	$ -7.22M	$ -6.57M	$ -5.31M	$ -5.13M
EBIT	$ -8.07M	$ -10.64M	$ -9.02M	$ -6.06M	$ -1.55M	$ -4.36M
EBITDA	$ -4.25M	$ -9.93M	$ -8.63M	$ -5.77M	$ -1.23M	$ -4.36M

Currency in USD

BioHarvest Sciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing